Systemic Therapeutics Corp. is a Canadian pre-clinical stage, biotechnology company specialized in the development of new therapies focusing on the master regulator of lipid metabolism, sterol regulatory-element binding proteins (SREBP), based on first-in-class SREBP inhibitors. The Company aims to provide new treatment options for metabolic conditions such as dyslipidemia and Non-Alcoholic Steatohepatitis (NASH).
Company Details
- Founded
- 2016
- Address
- 175 Longwood Rd S, Unit 305,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.SystemicTx.com
- Keywords
- Dyslipidemia, Metabolism, Genetics, Biotechnology, Drug development, Metabolic Disorders, NASH, cholesterol, Inborn Errors of Metabolism, SREBP inhibitors, PCSK9.
- HQ
- Hamilton, Ontario
Systemic Therapeutics Corp. Questions
Systemic Therapeutics Corp.'s website is http://www.SystemicTx.com
Systemic Therapeutics Corp.'s LinkedIn profile is https://ca.linkedin.com/company/systemic-therapeutics-corp
Systemic Therapeutics Corp.'s industry is
Biotechnology Research
Systemic Therapeutics Corp.'s top competitors are
The Climate Solutions Collaborative,
Century Therapeutics, Inc,
Raft,
Lpg Inventory Solutions,
Exerkine Corporation,
Triumvira Immunologics, Inc.,
Omniabio,
Start Me Up Niagara,
Cora Nutraceuticals Inc.,
Herb + Flora.
Systemic Therapeutics Corp.'s categories are Biotechnology Research
Systemic Therapeutics Corp.'s founding year is 2016
